Bogart Wealth’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.6K Sell
164
-5
-3% -$474 ﹤0.01% 899
2026
Q2
$14.5K Buy
169
+38
+29% +$3.33K ﹤0.01% 895
2026
Q1
$11.8K Buy
131
+11
+9% +$1.01K ﹤0.01% 868
2025
Q4
$10.8K Hold
120
– – ﹤0.01% 850
2025
Q3
$11.8K Hold
120
– – ﹤0.01% 795
2025
Q2
$10.9K Sell
120
-5
-4% -$483 ﹤0.01% 780
2025
Q1
$14.1K Sell
125
-95
-43% -$10.2K ﹤0.01% 674
2024
Q4
$23.2K Buy
220
+100
+83% +$10.7K ﹤0.01% 554
2024
Q3
$13K Sell
120
-10
-8% -$1.09K ﹤0.01% 635
2024
Q2
$14.1K Sell
130
-13
-9% -$1.53K ﹤0.01% 597
2024
Q1
$18.8K Buy
143
+10
+8% +$1.25K ﹤0.01% 526
2023
Q4
$16.2K Hold
133
– – ﹤0.01% 540
2023
Q3
$14.9K Hold
133
– – ﹤0.01% 524
2023
Q2
$19.3K Buy
133
+120
+923% +$16.3K ﹤0.01% 471
2023
Q1
$1.63K Sell
13
-11
-46% -$1.38K ﹤0.01% 934
2022
Q4
$3.03K Buy
24
+11
+85% +$1.28K ﹤0.01% 748
2022
Q3
$1K Hold
13
– – ﹤0.01% 963
2022
Q2
$1K Buy
13
+1
+8% +$119 ﹤0.01% 880
2022
Q1
$2K Sell
12
-1
-8% -$121 ﹤0.01% 715
2021
Q4
$2K Buy
+13
New +$1.7K ﹤0.01% 681

Other funds holding ZBH

Bogart Wealth's ZBH Position: Q3 2026 in Review

Bogart Wealth reduced its Zimmer Biomet (ZBH) stake by 3% in Q3 2026, selling an estimated $474 and leaving 164 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Bogart Wealth first reported a position in ZBH in Q4 2021 and has held it in 20 quarters since. The position peaked at $23.2K in Q4 2024. 931 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Bogart Wealth held 164 shares of Zimmer Biomet worth $14.6K as of Q3 2026.
  • Bogart Wealth sold 5 Zimmer Biomet shares in Q3 2026, an estimated $474.
  • Zimmer Biomet made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #899 holding.
  • Bogart Wealth first reported a position in Zimmer Biomet in Q4 2021 and has held it in 20 quarters since.
  • Bogart Wealth's Zimmer Biomet position peaked at $23.2K in Q4 2024.
  • 931 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.